Chemsex, Perceived Risks and Coping Strategies.

MSM Clinical Trial

— Chemsex  

Official title:

Chemsex Among Men Who Have Sex With Men : Perceived Risks and Coping Strategies, a Qualitative Study.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04584229
• Other study ID #: RECHMPL19_0091
• Status: Completed
• Start date: October 30, 2019
• Est. completion date: December 30, 2019

Study information

• Verified date: November 2020
• Source: University Hospital, Montpellier
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The research hypothesis is that access to prevention and harm and risk reduction associated with the use of psychoactive substances in a sexual context is insufficient for MSM practicing chemsex. This would lead to a lack of awareness of the risks taken and insufficient or inadequate strategies to protect themselves.

This qualitative study has a comprehensive objective. The aim is to identify the risks perceived by MSM practicing Chemsex and their coping strategies. The study is based on individual semi-directed interviews and focus group. The criteria for inclusion are: an age greater than or equal to 18 years, being a man having sex with men and having used psychoactive substances in a sexual context at least once in the past 12 months. Participants were recruited through a gay geo-social networking app on mobile phones on a voluntary basis. At the same tim+e, flyers presenting the study are also distributed to the "chemsex" consultations at the Montpellier University Hospital in France as well as to an association fighting against AIDS in Montpellier.

Data are subjected to an inductive method analysis, bringing out by constant comparison conceptualizing categories illustrating the experience and making it possible to identify and understand the risks felt and the coping strategies.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 15
• Est. completion date: December 30, 2019
• Est. primary completion date: December 30, 2019
• Accepts healthy volunteers: No
• Gender: Male
• Age group: 18 Years and older

Eligibility

Inclusion criteria:

• an age greater than or equal to 18 years

• being a man having sex with men

• having used psychoactive substances in a sexual context at least once in the past 12 months.

Exclusion criteria:

• to refuse to participate to the study

Related Conditions & MeSH terms

• Illicit Drugs
• MSM
• Sexual; Sexual Desire

Intervention

Other:
• Intervention
Intervention: comprehensive individual or collective interview, recorded and transcribed

Locations

Country	Name	City	State
France	Uhmontpellier	Montpellier

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Chemsex Paretic Risk Assessment	Chemsex Paretic Risk Assessment	1 day
Secondary	Description of the population leaving Chemsex	Description of the population leaving Chemsex	1 day